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RESEARCH ARTICLE
Is sperm hyaluronic acid binding ability predictive for clinical success of
intracytoplasmic sperm injection: PICSI vs. ICSI?
Attila Moka´nszki1*, Emese Varga To´thne´2, Be´la Bodna´r2, Zolta´n Ta´ndor2, Zsuzsanna Molna´r1, Attila Jakab3,
Aniko´ Ujfalusi1, and E´va Ola´h4
1Department of Laboratory Medicine, 2Assisted Reproduction Center, Kaali Institute, 3Department of Obstetrics and Gynecology, and
4Clinical Genetic Center, Department of Pediatrics, Clinical Center, University of Debrecen, Debrecen, Hungary
Abstract
Although intracytoplasmic sperm injection (ICSI) is now a widely-used technique, it is still of
interest to improve our knowledge as to which is the best spermatozoon to be selected for ICSI.
Infertile men have increased risks of producing aneuploid spermatozoa. Using hyaluronic acid
(HA)-binding sperm selection may reduce the genetic risks such as chromosomal aberrations of
offspring. In the present study we examined the clinical success of ICSI with HA-selected sperm
(‘physiologic’ ICSI, PICSI) compared to conventional ICSI, as well as the necessity to differentiate
patients according to the initial HA-binding assay result (HBA score) and whether the sperm
concentration or HBA score can provide additional information. We observed a significantly
higher fertilization rate (FR) of the PICSI group with460% HBA, implantation rate (IR) of the
PICSI group with 60% HBA, and clinical pregnanacy rate (CPR) in every PICSI group compared
to the ICSI groups (p50.01). We also observed a significantly higher life birth rate (LBR) in the
PICSI group with 60% HBA compared to ICSI patients with 60% HBA (p50.001). The
pregnancy loss rate (PLR) was significanly lower in PICSI patients compared to the ICSI group
(p50.0001). The FR, IR, CPR, and LBR of the PICSI group with550% HBA were significantly
higher and the PLR was lower than in the ICSI group with550% HBA (p50.01). A statistically
significant correlation was found between the sperm concentration and the HA-binding
capacity (r¼ 0.62, p50.001). We found a closer relationship between HBA score and FR
(r¼ 0.53, NS) than between sperm concentration and FR (r¼ 0.14, NS). HBA could be considered
for sperm selection prior to ICSI because of its success and apparant ability to reduce genetic
complications. However, this must be extended to a larger study.
Abbreviations: CPR: clinical pregnancy rate; FR: fertilization rate; FSH: follicle stimulating
hormone; GnRH: gonadotropin releasing hormone; HA: hyaluronic acid; HBA: HA-binding assay,
HA-binding ability; hCG: human chorionic gonadotropin; HspA2: heat shock-related 70 kDa
protein 2; ICSI: intracytoplasmic sperm injection; IR: implantation rate; IVF: in vitro fertilization;
LBR: life birth rate; NS: non-significant; PICSI: ICSI with HA-selected sperm (‘physiologic’ ICSI);
PLR: pregnancy loss rate; r: Pearson correlation coefficient; 2PN: two-pronuclear zygote, the
appearance of two pronuclei is the first sign of successful fertilizationQ1
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Introduction
Oligozoospermic men requiring intracytoplasmic sperm
injection (ICSI) often carry sperm populations characterised
by an increase in chromosomal aberrations and a compro-
mised DNA integrity. A higher incidence of numerical
[Palermo et al. 2000; Simpson and Lamb 2001; Van
Steirteghem et al. 2002] and structural chromosomal aberra-
tions [Bonduelle et al. 2002] have been associated in studies
in the embryos resulting from ICSI.
The selection of sperm for ICSI is commonly done via the
microscopic assessment of motility and morphology. Sperm
classified as normal morphology are found to host chromo-
somal aberrations [Celik-Ozenci et al. 2004]. Disomic and
diploid sperm have been found in all categories of morpho-
logical classification [Zavaczki et al. 2006].
Hyaluronic acid (HA) is thought to be critical within the
female reproductive tract when selecting functionally com-
petent sperm during in vivo fertilization. The human oocyte is
surrounded by the cumulus oophorus, whose major compo-
nent is HA, a high molecular weight glycosaminoglycan.
Developmentally mature sperm were found to bind to HA gels
similarly to the binding between sperm and zona pellucida.
The binding of sperm to HA in vitro is a selection process.
In another study it has been demonstrated that there are
*Addresss correspondence to Attila Moka´nszki, Department of
Laboratory Medicine, Clinical Center, University of Debrecen,


























































































































exceptions when motile sperm do not bind to HA [Huszar
et al. 2003].
Simultaneously with cytoplasmic extrusion in spermiogen-
esis, there is also a remodeling of the plasma membrane that
facilitates the formation of the zona pellucida- and HA-
binding sites [Huszar et al. 1997, 2003]. HA-binding
associated with the presence of the HA receptors on the
sperm surface is related to sperm development [Huszar and
Vigue 1993]. Sperm with HA-binding ability are viable
having either intact or slightly capacitated acrosomal status
and appear devoid of significant DNA degradation [Huszar
et al. 2007; Yagci et al. 2010].
Diminished expression of the heat shock-related 70 kDa
protein 2 (HspA2), a testis-specific chaperone protein, part of
the meiotic synaptonemal complex, causes meiotic defects
leading to aneuploidies [Kovanci et al. 2001]. There is a
relationship between diminished sperm development (asso-
ciated with oligozoo/asthenozoo/teratozoospermia), low
levels of HspA2 expression, increased frequency of chromo-
somal aneuploidies, the presence of apoptotic process, and
fragmented DNA [Huszar and Vigue 1993; Huszar et al.
2000, 2003, 2007; Yagci et al., 2010]. In vitro solid-state HA-
binding facilitates the selection of individual mature sperm
with low levels of chromosomal aneuploidies [Jakab et al.
2005]. Based on the percentage of bound sperm, three binding
zones were established: excellent (480%), moderate (60-
80%), and low (560%). The HA sperm selection method for
ICSI might reduce the potential genetic complications and
adverse public health effects of ICSI [Jakab et al. 2005].
In the present study we examined (1) the clinical success of
ICSI with HA-selected sperm (‘physiologic’ ICSI, PICSI)
compared to the conventional ICSI, (2) the necessity to
differentiate patients according to the initial HA-binding
assay result, and (3) whether the sperm concentration or the
HA-binding ability can give more information about fertil-
ization outcome. For this purpose, (i) we analyzed the clinical
outcome (fertilization rate (FR), implantation rate (IR),
clinical pregnancy rate (CPR), life birth rate (LBR), and
pregnancy loss rate (PLR)) of 250 infertile couples (idiopathic
infertile couples or infertility caused by male factor infertility)
conceived by PICSI or ICSI, (ii) we carried out initial HA-
binding score of all male partners, formed different groups
according to the results, and then analyzed the clinical
outcome, and finally (iii) we studied the correlation between
the sperm concentration, HA-binding capacity, and fertiliza-
tion rate.
Results
Clinical outcome of PICSI vs. ICSI
An average of 10.6 Metaphase II oocytes and 7.9 2PN zygotes
were produced. The average fertilization rate was 62.7%.
The male patients demonstrated average sperm concentration
of 33.3 106/mL with 52.6% HBA score. In all cases the
morphology of the embryos was normal (530% fragmenta-
tion; [WHO 2010]). The results of Study 1 are summarized in
Figure 1.
In the ICSI group the average sperm concentration proved
to be 39.2 106/mL, the HBA score 62.5%, the FR 56.5%, the
IR 17.12%, the CPR 29.22%, the LBR 0.42%, and the PLR
5.14%, respectively. In the ICSI group, where the HBA score
was460%, the average sperm concentration was 47.4 106/
mL, HBA score was 75.7%, FR was 60.14%, IR was 21.47%,
CPR was 31.85%, LBR was 0.58%, and PLR was 8.37%. In
the ICSI group with HBA score 60% the parameters found
were as follows: average sperm concentration: 20.1 106/mL,
the HBA score: 31.7%, the FR: 52.85%, the IR: 12.76%, the
CPR: 26.6%, the LBR: 0.27%, and the PLR: 1.9%.
Figure 1. Clinical outcome of PICSI vs. ICSI. (A)Q9 Fertilization rate (FR) of patients with HBA460%, patients with HBA 60%, and all patients; (B)
Implantation rate (IR) of patients with HBA460%, patients with HBA 60%, and all patients; (C) Clinical pregnancy rate (CPR) of patients with HBA
460%, patients with HBA 60%, and all patients; (D) Life birth rate (LBR) of patients with HBA460%, patients with HBA 60%, and all patients;
(E) Pregnancy loss rate (PLR) of patients with HBA460%, patients with HBA 60%, and all patients. Statistical significance (*) is indicated at
p50.05. HBA: hyaluronic acid (HA) binding ability;ICSI: intracytoplasmic sperm injection; PICSI: ICSI with HA-selected sperm (‘physiologic’ ICSI).

























































































































In the PICSI group the average sperm concentration was
25.6 106/mL associating with HBA score of 34.8%; the FR
was 64.5%; the IR 21.7%, the CPR 40.46%, the LBR 0.45%,
and the PLR 2%. In the PICSI group, where the HBA score was
460%, the average sperm concentration was measured as
35.5 106/mL, the HBA score 66.7%, the FR 73.36%, the IR
20.8%, the CPR 41.67%, the LBR 0.42%, and the PLR 2.2%. In
the PICSI group with HBA score 60% the same parameters
are as follows: average sperm concentration: 24.8 106/mL,
the HBA score: 32.3%, the FR: 55.7%, the IR: 22.6%, the CPR:
39.3%, the LBR: 0.49%, and the PLR: 1.99%.
The FR of the PICSI group with 460% HBA was
significantly higher than that in the ICSI group with460%
HBA (p50.01). The IR of the PICSI group with 60% HBA
proved to be significantly higher than that in the ICSI group
with 60% (p50.001). The CPR was significantly higher in
every PICSI group compared to the ICSI groups (p50.01).
We have observed a significantly higher LBR in the PICSI
group with 60% HBA compared to ICSI patients with the
same HBA ratio (60%; p50.001). PLR was significanly
lower in PICSI patients and in the PICSI group with above
60% HBA compared to the ICSI group and the ICSI patients
with460% HBA, respectively (p50.0001).
Characterization according to the HBA score
Patients were further differentiated into two groups: HA-
excellent (470%) and HA-low bound sperm (550%) groups
based upon their HA binding capacity (%). The ICSI group
with excellent HBA consisted of 69 couples and the ICSI
group with 550% HBA contained 32 patients. The PICSI
group with excellent HBA consisted of six couples and the
PICSI group with 550% HBA contained 87 patients. The
results of Study 2 are summarized in Figure 2.
In the ICSI group, where the HBA score was470%, the
average sperm concentration was 54.1 106/mL, the HBA
score 84.1%, the FR 70.14%, the IR 21.5%, the CPR 35.8%,
the LBR 0.58%, and the PLR 8.3%, respectively. In the ICSI
group with 550% HBA the average sperm concentration
proved to be 16.13 106/mL, the HBA score 24%, the FR
47.24%, the IR 12.5%, the CPR 30.8%, the LBR 0.26%, and
the PLR 9.15%. In the PICSI group, where the HBA score was
470%, the average sperm concentration was 54.1 106/mL,
the HBA score 83.1%, the FR 73.4%, the IR 20.8%, the CPR
41.7%, the LBR 0.4%, and the PLR 2.2%. In the PICSI group
with 550% HBA the average sperm concentration was
24.1 106/mL, the HBA score 28.5%, the FR 55.42%,
the IR 24.02%, the CPR 41.2%, the LBR 0.5%, and the
PLR 4.65%.
The FR, IR, CPR, and LBR of the PICSI group with550%
HBA were significantly higher and the PLR was significantly
lower than those in the ICSI group with 550% HBA
(p50.01). The PLR of the PICSI group with 470% HBA
proved to be significantly lower than that in the ICSI group
with470% HBA (p50.0001).
Correlation analysis between sperm concentration,
HA-binding capacity, and fertilization rate
The Pearson correlation (r) between the sperm concentration
and HA-binding capacity was determined by comparing all
samples in the ICSI and PICSI groups. The Pearson correl-
ation between the sperm concentration and FR and between
the HBA score and FR independent of treatment (ICSI or
PICSI), were respectively calculated. The results of the
correlation analysis are summarized in Figure 3.
A statistically significant positive correlation was found
between the sperm concentration and the HA-binding
Figure 2. Clinical outcome of PICSI vs. ICSI of patients with HA-excellent (HBA score470%) and HA-low bound sperm (HBA score550%).
(A) Fertilization rate (FR) ofQ9 patients with HBA470% and patients with HBA550%; (B) Implantation rate (IR) of patients with HBA470% and
patients with HBA550%; (C) Clinical pregnancy rate (CPR) of patients with HBA470% and patients with HBA550%; (D) Life birth rate (LBR) of
patients with HBA470% and patients with HBA550%; (E) Pregnancy loss rate (PLR) of patients with HBA470% and patients with HBA550%.
Statistical significance (*) is indicated at p50.05. HBA: hyaluronic acid (HA) binding ability; ICSI: intracytoplasmic sperm injection; PICSI: ICSI
with HA-selected sperm (‘physiologic’ ICSI).

























































































































capacity (r¼ 0.62, p50.001). We found a higher positive
correlation between HBA score and FR (r¼ 0.53, NS) than
between sperm concentration and FR (r¼ 0.14, NS), but the
difference was not statistically significant. In the ICSI and in
the PICSI groups a higher positive correlation between HBA
score and FR (r¼ 0.51 and r¼ 0.49, NS) than between sperm
concentration and FR (r¼ 0.22 and r¼ 0.19, NS) was
observed. This association was not statistically significant.
Discussion
We compared conventional ICSI (n¼ 140) to ICSI in which
the spermatozoa were selected for their capacity to bind to
HA (PICSI, n¼ 110). We observed a significantly higher FR
in the PICSI group with460% initial HBA; IR of the PICSI
group with 60% HBA, and CPR in every PICSI group
compared to the ICSI groups (p50.01). We also observed a
significantly higher LBR in the PICSI group with 60% HBA
compared to ICSI of patients with 60% HBA (p50.001).
PLR was significantly lower in PICSI patients compared to
the same parameter in the ICSI group (p50.0001). When the
outcome was assessed as a function of the HBA score, the FR,
IR, CPR, and LBR of the PICSI group with550% HBA were
significantly higher and the PLR was significantly lower than
in the ICSI group with550% HBA (p50.01). A statistically
significant positive correlation was found between the sperm
concentration and the HA-binding capacity (r¼ 0.62,
p50.001). We found a closer relationship between HBA
score and FR (r¼ 0.53, NS) than between sperm concentra-
tion and FR (r¼ 0.14, NS).
Previous studies regarding the development and function
of biochemical and molecular markers of human sperm are
supported by the above clinical results. A relationship
between HA selected sperm and increased levels of develop-
mental maturity [Cayli et al. 2004; Huszar et al. 1994, 2003],
as well as nuclear [Kovanci et al. 2001; Jakab et al. 2005], and
cytoplasmic integrity [Huszar et al. 1997; Sakkas et al. 1999]
have been demonstrated.
A similar increase in IR, CPR, and lower PLR values was
found by Worrilow and colleagues [Worrilow et al. 2006;
Worrilow et al. 2007; Worrilow et al. 2012]. Others compared
conventional sperm selection and the use of sperm selected
from a liquid source of HA and an increased IR was found
[Parmegiani et al. 2010]. The same positive trend was
observed comparing polyvinylpyrrolidone-ICSI (n¼ 110) and
PICSI (n¼ 92) treatments [Me´ne´zo and Nicollet 2004]. Q2In a
study of 50 couples, a higher FR was observed when HA-
selected spermatozoa were injected into oocytes [Nasr-
Esfahani et al. 2008]. These studies, in accordance with
ours, did not demonstrate any negative effect on embryogen-
esis using HA sperm selection for ICSI, but they all was ‘in-
house’ developed HA slides.
In two further reports, no association was found between
HA binding and FR, fragmentation, and embryo quality
though they used washed sperm [Choe et al. 2012; Tarozzi
et al. 2009]. In another report the clinical outcome of sperm
functional assays including HBA was studied [Nijs et al.
2009]. A correlation of HA-binding was found with morph-
ology, but it did not predict FR and CPR. Another recent
study did not find any differences in FR, IR, and CPR
Figure 3. Correlation analysis between the sperm concentrationQ9 and HBA score (A), between the sperm concentration and FR (B) and between the
HBA score and FR (C). A statistically significant correlation was found between the sperm concentration and the HA-binding capacity. Higher positive
correlation was found between HBA score and FR than between sperm concentration and FR. HBA: hyaluronic acid (HA) binding ability;
FR: fertilization rate; r: Pearson correlation coefficient; NS: non-significant.

























































































































between ICSI and PICSI patients. The only benefit of
injecting HA selected sperm was a lower PLR which
consequently translated to a higher LBR, both of
which were not statistically significant [Majumdar and
Majumdar 2013].
No visual integrity of the DNA in selected sperm can be
assessed which can basically determine the overall success of
ICSI. When natural and assisted reproduction fails defects in
sperm chromatin have been blamed [Bungum et al. 2007;
Carrell et al. 2007]. Sperm DNA damage was found to be
positively correlated with PLR when 11 studies involving
1,549 in vitro fertilization (IVF) and ICSI cycles was
systematically reviewed [Zini et al. 2008]. It is well known
that the proportion of immature sperm closely correlates with
chromosomal disomies [Kovanci et al. 2001]. The relation-
ship between the frequencies of chromosomal aneuploidies
and diminished sperm maturity is thought to reflect that
cytoplasmic retention and diminished maturity in sperm are
associated with a low expression of the HspA2 [Eddy 1999;
Huszar et al. 2000]. The relationship between sperm zona
pellucida binding competence and maturity has been
identified earlier. In the semen samples there were sperm
with various degrees of cytoplasmic retention, but all sperm
bound to the zona pellucida were mature as characterized with
the absence of any cytoplasmic retention. Diminished HspA2
chaperone activity found in developmentally immature sperm
is thought to be connected with a diminished presence of
DNA repair enzymes, causing DNA chain breaks and
fragmentation [Dix et al. 1996; Eddy 1999; Huszar et al.
2000]. There is a correlation between the decreased levels of
expression of the HspA2 chaperone and sperm cellular
development as well as IVF success [Ergur et al. 2002;
Huszar et al. 1992, 2000]. Van Steirteghem et al. [2002] found
increased rates of de novo numerical and cytogenetically
detectable structural chromosomal aberrations following
ICSI. The low concentration of HspA2 in the undeveloped
spermatozoa likely suggests numerical chromosomal aberra-
tions in sperm of oligozoospermic or severely oligozoosper-
mic men [Huszar et al. 2007].
An enhancement of DNA and chromosomal integrity was
demonstrated in HA-bound sperm by Yagci et al. [2010] when
they analyzed HA-bound sperm with acridine orange fluor-
escence and they did not find DNA fragmentation. Selecting
individual mature sperm with low levels of chromosomal
disomy, diploidy, and sex chromosome disomy is facilitated
by HA-binding and might reduce the potential genetic
complications in male candidates for ICSI [Jakab et al.
2005]. It has been observed that almost all HA-bound
spermatozoa are devoid of persistent histones, which
correlated with DNA strand breakage [Sati et al. 2004].
After ICSI, no sperm function tests were well correlated
with FR. These results are in line with the data of several
studies [Bakos et al. 2008; Henkel et al. 2003; Nasr-Esfahani
et al. 2008] but contradictory to the data presented above,
where we found PICSI proved to be significantly more
effective than ICSI in respect of clinical success for patients
with a low initial HBA score (50%). Based on our results
HA selection becomes an important factor in cases with low
binding scores, where the expected number of normal sperm
is much lower. It has been observed in a single study where a
correlation was found between sperm HA-binding capacity
and FR after IVF [Pregl Breznik et al. 2013]. Our results
indicate that sperm selection by HA binding is promising and
significantly improves the success of the result in patients
with a low HBA score. We conclude that HBA screening prior
to ICSI may be useful to increase clinical success. It has been
demonstrated that injection of spermatozoa recovered from
HA-containing products had no negative effects on post-
injection zygote development [Balaban et al. 2003; Barak
et al. 2001]. A statistically significant reduction in PLR was
observed in patients with a low HBA score. The use of HA
sperm selection may be considered in patients with an initial
HBA score of 50%. To determine the use of HA-bound
sperm in ICSI, the use of HBA score would be beneficial
since it could offer a balance to unnecessary treatment.
Materials and Methods
Patients
A total of 250 couples referred to the Assisted Reproduction
Center, Kaali Institute, Medical and Health Science Center,
University of Debrecen for ICSI were studied. The study was
done between January 2012 and March 2013. In this period,
140 ICSI and 110 PICSI were carried out on the basis of the
sperm HA-binding ability of the male partner (HBA score):
when initial HBA score was 460% ICSI was carried out
(n¼ 98), in cases with HBA score 60% PICSI was
performed (n¼ 102). The ICSI group included 42 couples
where the sperm number and the HBA score was low and
unsuitable for PICSI. Q3We carried out eight control PICSI
where the HBA score was460%.
Women under the age of 40 (mean: 33.18, range: 22–40)
with regular (21–35 days) menstrual cycles, with normal
baseline follicle stimulating hormone (FSH) level (12 IU/L)
were eligible. Within the overall studied population the
average male age was 35.8 years (range: 23–45). Patients
excluded from the study were as follows: those from whom
testicular sperm were taken, who got donor or cryopreserved
gametes, received preimplantation genetic diagnosis, under-
went sperm sorting procedures, patients whose maternal age
was440 years, and those who demonstrated a sperm count
510,000 motile sperm/mL.
Prior to the study, all patients were given detailed
information about the aim and method of investigation and
their consents were obtained. All protocols had to be
approved by the author’s respective Institutional Review
Board (IRB) for human subjects (IRB reference number:
2976/2012-EHR).
Stimulation protocols
Standard stimulation protocols, gonadotropin releasing hor-
mone (GnRH) agonist long (n¼ 75), short (n¼ 120), and
GnRH antagonist (n¼ 55), were used. The stimulation
protocol and dose of gonadotropins were not standardized
for the study; the decision was made by the physician.
For the long protocol, GnRH agonist was started in the
midluteal phase. During suppression the dosage was reduced
to half and stimulation with either recombinant FSH or human
menopausal gonadotropin, or the combination of the two were

























































































































used. For the short protocol, the GnRH agonist was started on
cycle day 2 and gonadotropin stimulation was initiated on day
3. In the case of the antagonist protocol, stimulation was
started on day 2 of the cycle and the GnRH antagonist was
started when the largest follicles had reached 13–14 mm in
size. When at least two follicles reached 17 mm in diameter,
recombinant human chorionic gonadotropin (hCG) was used
to trigger ovulation. Transvaginal oocyte retrieval was
performed 35–36 h later.
Semen analysis and hyaloronic acid binding assay
Semen specimens were collected after a requested abstinence
of two to three days on the day of the oocyte retrieval. The
sperm sample was maintained at room temperature (18–
28 C) for 30 to 60 min to allow it to liquefy. Semen analysis
was performed manually according to WHO guidelines and
morphology was examined using strict criteria [WHO 2010].
The HBA-test (hyaloronic acid binding assay) (MidAtlantic
Diagnostics, Martlon, NJ, USA) was carried out at room
temperature: the sample was mixed and a pipette of 7–10 ml
was placed near the center of the chamber.Q4 The CELL-VU
gridded cover slip was located over the chamber to avoid air
bubble formation. The chamber was incubated at room
temperature for at least 10 min, but not more than 20 min:
this period proved to be necessary for sperm to bind to HA
(according to the HBA-test protocol). The number of bound,
motile sperm and the totality of motile sperm was scored. At
least 200 spermatozoa in the same square or the entire 100
squares were counted. The ratio of hyaluronic binding motile
sperm was calculated as follows:
%Bound ¼ 100 Bound Motile=Total Motile:
Fertilization
Gradient centrifugation (600 g for 10 min) was used to
separate the cellular components of semen (PureCeption
Sperm Washing Solution, SAGE, Pasadena, CA, USA).
Following centrifugation the supernatant was removed and
the sediment was washed twice (Quinn’s Advantage Sperm
Washing Medium, SAGE, Pasadena, CA, USA; 600 g for
10 min). The supernatant was removed again and the sediment
was diluted.
In order to select the morphologically ‘best’ spermatozoon,
sperm were placed into standard ICSI dishes which were later
injected into oocytes. We placed the final sperm suspension of
PICSI patients upon microdots of hyaluronic acid in the
PICSI Sperm Selection Device (Biocoat, Inc., Horsham, PA,
USA) and then overlaid it with oil (SAGE, Pasadena, CA,
USA). After an incubation period of 5 to 10 min, HBA sperm
were selected as per the manufacturer’s instructions. We
selected spermatozoa bound to HA in the junction zone of the
two droplets and it was easy to detach then by an injecting
pipette (ICSI Micropipette; ORIGIO, Charlottesville, VA,
USA) and subsequently injected into oocytes.
Embryo culture
In the presence of two pronuclei fertilization was confirmed.
The embryos were transferred to Quinn’s Advantage Protein
Plus Cleavage Medium at this stage (SAGE) and in
microdroplets of 20–25mL under Washed Oil for Tissue
Culture, groups of 3–5 were cultured until the 6–8 cell stage
(SAGE). After this, embryos were put to Q5Quinn’s Advantage

Protein Plus Blastocyst Medium (SAGE).
One, two, or three embryos were transferred following 3 or
5 d of fertilization. It was the couple’s decision of how many
embryos to be transferred after consulting with their physician.
The morphology of the embryos was the basis for the transfer.
Statistical analysis
Statistical analyses were performed with commercial software
SigmaStat and SPSS. Sample normality was assessed using
Shapiro-Wilk test, sample homogeneity using Barlett test.
Differences in the sperm concentration, HA-binding ability,
FR, IR, CPR, LBR, and PLR between the ICSI and PICSI
groups were analyzed using Mann-Whitney/Wilcoxon Two-
Sample Test, Kruskal-Wallis test (when normality does
not exist), and Two-sample t-probe (when normality exists).
A value of p50.05 was considered a significant difference.
Correlation analyses between the sperm concentration,
HA-binding capacity, and FR using all samples in the two
groups were examined with Pearson correlation test.
It was the number of eggs fertilized with the given method
that determined the fertilization rate (FR) for each patient.
Implantation rate (IR) was calculated from the number of
intrauterine sacs/the number of embryos transferred in each
patient. There is an agreement that clinical pregnancy means
that fetal cardiac activity is present within an intrauterine
gestational sac. Vaginal ultrasound was used to assess preg-
nancy loss rate (PLR) and it means the proportion of patients
demonstrating an intrauterine sac at 5–7 w of gestation and
those where no fetal cardiac activity was present at 8–10 w of
gestation.
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